Technical Analysis for GBIO - Generation Bio Co.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Volume Surge | Other | -8.87% | |
Inside Day | Range Contraction | -8.87% | |
Wide Bands | Range Expansion | -8.87% | |
Doji - Bearish? | Reversal | -9.82% | |
Outside Day | Range Expansion | -9.82% | |
Wide Bands | Range Expansion | -9.82% | |
NR7 | Range Contraction | -8.21% | |
Narrow Range Bar | Range Contraction | -8.21% |
Alert | Time |
---|---|
Down 3% | about 9 hours ago |
Fell Below Previous Day's Low | about 9 hours ago |
Down 2 % | about 9 hours ago |
Down 1% | about 9 hours ago |
Fell Below 10 DMA | about 9 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 07/31/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Rare Diseases Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.98 |
52 Week Low | 0.86 |
Average Volume | 175,375 |
200-Day Moving Average | 2.54 |
50-Day Moving Average | 3.09 |
20-Day Moving Average | 2.96 |
10-Day Moving Average | 2.77 |
Average True Range | 0.25 |
RSI (14) | 38.65 |
ADX | 16.97 |
+DI | 16.64 |
-DI | 27.60 |
Chandelier Exit (Long, 3 ATRs) | 2.74 |
Chandelier Exit (Short, 3 ATRs) | 3.28 |
Upper Bollinger Bands | 3.46 |
Lower Bollinger Band | 2.47 |
Percent B (%b) | 0.1 |
BandWidth | 33.55 |
MACD Line | -0.13 |
MACD Signal Line | -0.11 |
MACD Histogram | -0.0231 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.84 | ||||
Resistance 3 (R3) | 2.87 | 2.80 | 2.80 | ||
Resistance 2 (R2) | 2.80 | 2.73 | 2.79 | 2.78 | |
Resistance 1 (R1) | 2.69 | 2.69 | 2.66 | 2.66 | 2.76 |
Pivot Point | 2.62 | 2.62 | 2.61 | 2.61 | 2.62 |
Support 1 (S1) | 2.51 | 2.55 | 2.48 | 2.48 | 2.38 |
Support 2 (S2) | 2.44 | 2.51 | 2.43 | 2.36 | |
Support 3 (S3) | 2.33 | 2.44 | 2.35 | ||
Support 4 (S4) | 2.30 |